Try a new search

Format these results:

Searched for:

in-biosketch:true

person:allenj08

Total Results:

123


PERORAL CHOLANGIOSCOPY WITH GASTROSCOPES: SEE MORE, DO MORE! [Meeting Abstract]

Widmer, Jessica L.; Modayil, Rani J.; Friedel, David; Allendorf, John; Grendell, James H.; Stavropoulos, Stavros N.
ISI:000434248200310
ISSN: 0016-5107
CID: 3522472

A Prospective Randomized Multicenter Trial of Distal Pancreatectomy With and Without Routine Intraperitoneal Drainage

Van Buren, George; Bloomston, Mark; Schmidt, Carl R; Behrman, Stephen W; Zyromski, Nicholas J; Ball, Chad G; Morgan, Katherine A; Hughes, Steven J; Karanicolas, Paul J; Allendorf, John D; Vollmer, Charles M; Ly, Quan; Brown, Kimberly M; Velanovich, Vic; Winter, Jordan M; McElhany, Amy L; Muscarella, Peter; Schmidt, Christian Max; House, Michael G; Dixon, Elijah; Dillhoff, Mary E; Trevino, Jose G; Hallet, Julie; Coburn, Natalie S G; Nakeeb, Attila; Behrns, Kevin E; Sasson, Aaron R; Ceppa, Eugene P; Abdel-Misih, Sherif R Z; Riall, Taylor S; Silberfein, Eric J; Ellison, Edwin C; Adams, David B; Hsu, Cary; Tran Cao, Hop S; Mohammed, Somala; Villafañe-Ferriol, Nicole; Barakat, Omar; Massarweh, Nader N; Chai, Christy; Mendez-Reyes, Jose E; Fang, Andrew; Jo, Eunji; Mo, Qianxing; Fisher, William E
OBJECTIVE:The objective of this study was to test the hypothesis that distal pancreatectomy (DP) without intraperitoneal drainage does not affect the frequency of grade 2 or higher grade complications. BACKGROUND:The use of routine intraperitoneal drains during DP is controversial. Prior to this study, no prospective trial focusing on DP without intraperitoneal drainage has been reported. METHODS:Patients undergoing DP for all causes at 14 high-volume pancreas centers were preoperatively randomized to placement of a drain or no drain. Complications and their severity were tracked for 60 days and mortality for 90 days. The study was powered to detect a 15% positive or negative difference in the rate of grade 2 or higher grade complications. All data were collected prospectively and source documents were reviewed at the coordinating center to confirm completeness and accuracy. RESULTS:A total of 344 patients underwent DP with (N = 174) and without (N = 170) the use of intraperitoneal drainage. There were no differences between cohorts in demographics, comorbidities, pathology, pancreatic duct size, pancreas texture, or operative technique. There was no difference in the rate of grade 2 or higher grade complications (44% vs. 42%, P = 0.80). There was no difference in clinically relevant postoperative pancreatic fistula (18% vs 12%, P = 0.11) or mortality (0% vs 1%, P = 0.24). DP without routine intraperitoneal drainage was associated with a higher incidence of intra-abdominal fluid collection (9% vs 22%, P = 0.0004). There was no difference in the frequency of postoperative imaging, percutaneous drain placement, reoperation, readmission, or quality of life scores. CONCLUSIONS:This prospective randomized multicenter trial provides evidence that clinical outcomes are comparable in DP with or without intraperitoneal drainage.
PMID: 28692468
ISSN: 1528-1140
CID: 3487002

Comment on: Clinicopathological study on metachronous double cholangiocarcinomas of perihilar and subsequent distal bile duct origin [Comment]

Allendorf, John
PMID: 28318553
ISSN: 1532-7361
CID: 3487322

Differences in single gland and multigland disease are seen in low biochemical profile primary hyperparathyroidism

Lim, James Y; Herman, Max C; Bubis, Lev; Epelboym, Irene; Allendorf, John D; Chabot, John A; Lee, James A; Kuo, Jennifer H
BACKGROUND:Primary hyperparathyroidism is characterized by increased levels of serum calcium and parathyroid hormone. Recently, 2 additional mild biochemical profiles have emerged, normocalcemic and normohormonal primary hyperparathyroidism. We reviewed our surgical experience of mild biochemical profile patients and compared them with classic primary hyperparathyroidism patients. METHODS:test. A logistic regression was performed to identify significantly independent predictor variables for multigland disease. RESULTS:A total of 573 patients underwent parathyroidectomy for primary hyperparathyroidism (classic, n = 405; normohormonal, n = 96; normocalcemic, n = 72). Normocalcemic primary hyperparathyroidism was associated with multigland disease in 43 (45%, P < .001) patients as compared with the normohormonal (7, 10%) and classic (36, 9%) groups. On logistic regression, significant predictors for multigland disease were the normocalcemic subtype and positive family history. Twelve month biochemical normalization rates after operative treatment were >98% in all 3 groups. CONCLUSION:Our series shows that normocalcemic primary hyperparathyroidism is associated with a high incidence of multigland disease. Normohormonal disease is similar to classic disease patients with >90% presenting with single adenomas. Excellent rates of biochemical normalization can be obtained by operative treatment in all 3 groups.
PMID: 27847113
ISSN: 1532-7361
CID: 3486982

Population-Level Incidence and Predictors of Surgically Induced Diabetes and Exocrine Insufficiency after Partial Pancreatic Resection

Elliott, Irmina A; Epelboym, Irene; Winner, Megan; Allendorf, John D; Haigh, Philip I
CONTEXT/BACKGROUND:Endocrine and exocrine insufficiency after partial pancreatectomy affect quality of life, cardiovascular health, and nutritional status. However, their incidence and predictors are unknown. OBJECTIVE:To identify the incidence and predictors of new-onset diabetes and exocrine insufficiency after partial pancreatectomy. DESIGN/METHODS:We retrospectively reviewed 1165 cases of partial pancreatectomy, performed from 1998 to 2010, from a large population-based database. MAIN OUTCOME MEASURES/METHODS:Incidence of new onset diabetes and exocrine insufficiency RESULTS: Of 1165 patients undergoing partial pancreatectomy, 41.8% had preexisting diabetes. In the remaining 678 patients, at a median 3.6 months, diabetes developed in 274 (40.4%) and pancreatic insufficiency developed in 235 (34.7%) patients. Independent predictors of new-onset diabetes were higher Charlson Comorbidity Index (CCI; hazard ratio [HR] = 1.62 for CCI of 1, p = 0.02; HR = 1.95 for CCI ≥ 2, p < 0.01) and pancreatitis (HR = 1.51, p = 0.03). There was no difference in diabetes after Whipple procedure vs distal pancreatic resections, or malignant vs benign pathologic findings. Independent predictors of exocrine insufficiency were female sex (HR = 1.32, p = 0.002) and higher CCI (HR = 1.85 for CCI of 1, p < 0.01; HR = 2.05 for CCI ≥ 2, p < 0.01). Distal resection and Asian race predicted decreased exocrine insufficiency (HR = 0.35, p < 0.01; HR = 0.54, p < 0.01, respectively). CONCLUSION/CONCLUSIONS:In a large population-based database, the rates of postpancreatectomy endocrine and exocrine insufficiency were 40% and 35%, respectively. These data are critical for informing patients' and physicians' expectations.
PMID: 28406793
ISSN: 1552-5775
CID: 3486992

Pure NOTES for Subepithelial Tumors: EFTR and Ster in the US [Meeting Abstract]

Stavropoulos, Stavros N.; Modayil, Rani J.; Friedel, David; Saitta, Patrick; Brathwaite, Collin; Allendorf, John; Peller, Abraham; Grendell, James H.
ISI:000392524200371
ISSN: 0016-5107
CID: 3514102

Progression of Incidental Intraductal Papillary Mucinous Neoplasms of the Pancreas in Liver Transplant Recipients

Dorfman, Valerie; Verna, Elizabeth C; Poneros, John M; Sethi, Amrita; Allendorf, John D; Gress, Frank G; Schrope, Beth A; Chabot, John A; Gonda, Tamas A
OBJECTIVES/OBJECTIVE:Intraductal papillary mucinous neoplasms (IPMNs) are premalignant pancreatic cysts commonly found incidentally. Immunosuppression accelerates carcinogenesis.Thus, we aimed to compare IPMN progression in liver transplant (LT) recipients on chronic immunosuppression to progression among an immunocompetent population. METHODS:We retrospectively assessed adult LT recipients between 2008 and 2014 for imaging evidence of IPMN. Diagnosis of IPMN was based on history, imaging, and cyst fluid analysis. The immunocompetent control group consisted of nontransplant patients from our pancreatic cyst surveillance program with IPMN under surveillance for greater than 12 months between 1997 and 2013. Four hundred fifty-four patients underwent LT in the study period and had cross-sectional imaging. RESULTS:The prevalence of suspected IPMN was 6.6% (30 of 454). Compared with 131 controls, the transplant cohort was younger, with increased prevalence of diabetes and smoking. The prevalence of other risk factors for IPMN progression (history of pancreatitis, family history of pancreatic cancer) was similar. After an average follow-up of 31 months, most cysts increased in diameter, with a similar increase of dominant cyst (0.4 cm vs 0.5 cm; P = 0.6). Type of immunosuppression was not associated with the increased rate of cyst growth. CONCLUSIONS:Our findings suggest that LT recipients with incidental IPMN can be managed under similar guidelines as immunocompetent patients.
PMID: 26495782
ISSN: 1536-4828
CID: 3486802

Natural Orifice Endoscopic Surgery (NOTES) Techniques for Full Thickness R0 Endoscopic Resection of Deep Seated Subepithelial Tumors (SETs): a Single Center Experience [Meeting Abstract]

Stavropoulos, Stavros N.; Modayil, Rani J.; Friedel, David; Brathwaite, Collin E.; Allendorf, John; Grendell, James H.
ISI:000209931400037
ISSN: 0016-5107
CID: 3412772

Demographic features and natural history of intermediate-risk multifocal versus unifocal intraductal papillary mucinous neoplasms

Rosenblatt, Russell; Dorfman, Valerie; Epelboym, Irene; Poneros, John M; Sethi, Amrita; Lightdale, Charles; Woo, Yanghee; Gress, Frank G; Allendorf, John D; Schrope, Beth A; Chabot, John A; Gonda, Tamas A
OBJECTIVES/OBJECTIVE:This study compares the progression of multifocal (MF) intraductal papillary mucinous neoplasms (IPMNs) to unifocal (UF) lesions. METHODS:We performed a retrospective review of demographics, risk factors, and cyst characteristics of a prospectively maintained database of 999 patients with pancreatic cysts. Patients included had IPMN under surveillance for 12 months or more. Those with high-risk stigmata were excluded. Cyst size progression and development of worrisome features were compared between MF and UF cohorts. We evaluated whether the dominant cyst in MF-IPMN had more significant growth than did the other cysts. RESULTS:Seventy-seven patients with MF-IPMN and 54 patients with UF-IPMN, with mean follow-up of 27 and 34 months, met the criteria. There were no significant differences between demographics, risk factors, or initial cyst sizes. Fifty-seven percent of MF dominant cysts and 48% of UF cysts increased in size (P = 0.31). Progression in MF was more likely in the dominant cyst (P < 0.05). There were no significant differences in the development of mural nodules or increase in cyst size to more than 3 cm. CONCLUSIONS:Demographics of both cohorts were similar, as was the overall incidence of worrisome features. Because meaningful size progression primarily occurred in the dominant cyst, our findings support surveillance based on the dominant cyst in MF disease.
PMID: 25411806
ISSN: 1536-4828
CID: 3486772

The role of molecular analysis in the diagnosis and surveillance of pancreatic cystic neoplasms

Winner, Megan; Sethi, Amrita; Poneros, John M; Stavropoulos, Stavros N; Francisco, Peter; Lightdale, Charles J; Allendorf, John D; Stevens, Peter D; Gonda, Tamas A
CONTEXT/BACKGROUND:Molecular analysis of pancreatic cyst fluid obtained by EUS-FNA may increase diagnostic accuracy. We evaluated the utility of cyst-fluid molecular analysis, including mutational analysis of K-ras, loss of heterozygosity (LOH) at tumor suppressor loci, and DNA content in the diagnoses and surveillance of pancreatic cysts. METHODS:We retrospectively reviewed the Columbia University Pancreas Center database for all patients who underwent EUS/FNA for the evaluation of pancreatic cystic lesions followed by surgical resection or surveillance between 2006-2011. We compared accuracy of molecular analysis for mucinous etiology and malignant behavior to cyst-fluid CEA and cytology and surgical pathology in resected tumors. We recorded changes in molecular features over serial encounters in tumors under surveillance. Differences across groups were compared using Student's t or the Mann-Whitney U test for continuous variables and the Fisher's exact test for binary variables. RESULTS:Among 40 resected cysts with intermediate-risk features, molecular characteristics increased the diagnostic yield of EUS-FNA (n=11) but identified mucinous cysts less accurately than cyst fluid CEA (P=0.21 vs. 0.03). The combination of a K-ras mutation and ≥2 loss of heterozygosity was highly specific (96%) but insensitive for malignant behavior (50%). Initial data on surveillance (n=16) suggests that molecular changes occur frequently, and do not correlate with changes in cyst size, morphology, or CEA. CONCLUSIONS:In intermediate-risk pancreatic cysts, the presence of a K-ras mutation or loss of heterozygosity suggests mucinous etiology. K-ras mutation plus ≥2 loss of heterozygosity is strongly associated with malignancy, but sensitivity is low; while the presence of these mutations may be helpful, negative findings are uninformative. Molecular changes are observed in the course of cyst surveillance, which may be significant in long-term follow-up.
PMID: 25791547
ISSN: 1590-8577
CID: 3486792